MedPath

Access to Kidney Transplantation in Minority Populations

Not Applicable
Recruiting
Conditions
Kidney Diseases
Interventions
Other: Kidney Transplant Fast Track (KTFT)
Other: Peer Navigation (PN)
Registration Number
NCT04615819
Lead Sponsor
University of New Mexico
Brief Summary

Hispanic/Latino (HL) and American Indian (AI) patients are more likely than whites to have kidney failure, but less likely to complete transplant evaluation or receive a kidney transplant (KT), the best treatment for kidney failure. Using comparative effectiveness research methods, we will conduct a pragmatic randomized trial to compare the efficacy and cost- effectiveness of two approaches to help HL and AI patients overcome barriers to completing transplant evaluation and receiving a KT: a streamlined KT evaluation process and a peer-assisted evaluation program; and, we will determine best practices to assist other transplant centers in implementing the better program. Findings from this work may help reduce disparities in transplant evaluation and KT.

Detailed Description

The AKT-MP study will assess whether Kidney Transplant Fast Track (KTFT), a streamlined KT evaluation process, or peer navigators (PN) who were former KT patients to help patients "navigate" their way through KT evaluation, can help vulnerable patients with kidney failure overcome barriers to transplant listing. After culturally and contextually adapting the two interventions, we will use a comparative effectiveness (CER) approach to conduct a pragmatic randomized trial of 398 kidney failure patients to compare the efficacy and effectiveness of the two approaches in disadvantaged groups at a university-affiliated transplant center with large HL and AI kidney failure patient populations, and we will compare results to historic comparison populations (local and national). We will assess facilitators and barriers to widespread implementation and conduct a cost effectiveness analysis. Although it is expected that KTFT will be more effective than PN, KTFT may also be more costly, requiring significant administrative and clinical changes in the transplant center, which may be impractical to maintain. Further, KTFT may lead to more patient ambivalence because the shortened evaluation period will give them less time to consider their treatment options. Thus, an important aspect of the proposed study is to comparative the effectiveness of the two methods. Ultimately, our study will inform transplant programs faced with disparities in KT about which disparity-reducing intervention to use given their particular needs and resources.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
398
Inclusion Criteria
  • Undergoing kidney transplant evaluation at the University of New Mexico
  • Greater than or equal to 18 years of age
  • Mentally competent
Exclusion Criteria
  • Children less than 18 years of age are excluded because all research-related measurements are designed for patients over the age of 18. Children less than 18 years of age have dissimilar decision-making authority as a result of their developmental stage and dependency on adult guardians who must make all their transplant-related decisions, as required by all pediatric transplant centers. The proposed study focuses only on adult transplant patients.
  • Waitlisted at another transplant center
  • Prior kidney transplant
  • Incarcerated patients
  • Pregnant women
  • Active systemic infection
  • Non-skin malignancy or melanoma in the past 2 years
  • Known cognitive impairment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm 1Kidney Transplant Fast Track (KTFT)KTFT
Arm 2Peer Navigation (PN)PN
Primary Outcome Measures
NameTimeMethod
Rate of KT evaluation completionThrough study completion, an average of 1 year

Completion of evaluation for KT and placement on the transplant waiting list.

Secondary Outcome Measures
NameTimeMethod
Patient Reported Quality of LifeThrough study completion, an average of 1 year

We will use the PROMIS Scale v1.2 Global Health measure to assess quality of life (QOL), which includes items relevant to patients with kidney disease, including overall health, physical limitations, work, pain, energy, and emotional problems.

KT ambivalenceThrough study completion, an average of 1 year

KT ambivalence will be assessed with the Decisional Conflict Scale, with questions rating from strongly agree to strongly disagree.

Trial Locations

Locations (1)

University of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath